-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RG-6468 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RG-6468 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RG-6468 in Solid Tumor Drug Details: RG-6468 (RO-7566802) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-701 in High-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-701 in High-Grade Glioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-701 in High-Grade Glioma Drug Details: SL-701 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efineptakin Alfa in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efineptakin Alfa in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Efineptakin Alfa in Triple-Negative Breast Cancer (TNBC) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pelabresib in Post-Polycythemia Vera Myelofibrosis (PPV-MF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pelabresib in Post-Polycythemia Vera Myelofibrosis (PPV-MF) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pelabresib in Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drug Details: Pelabresib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TP-04 in Rosacea
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TP-04 in Rosacea report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TP-04 in Rosacea Drug Details: TP-04 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Runimotamab in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Runimotamab in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Runimotamab in Solid Tumor Drug Details: BTRC-4017A (RG-6194) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vismodegib in Meningioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vismodegib in Meningioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vismodegib in Meningioma Drug Details: Vismodegib (Erivedge) belongs to the class of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vismodegib in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vismodegib in Refractory Multiple Myeloma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vismodegib in Refractory Multiple Myeloma Drug Details: Vismodegib (Erivedge) belongs...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Regorafenib in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Regorafenib in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Regorafenib in Esophageal Cancer Drug Details: Regorafenib (BAY 73-4506, Stivarga) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tenecteplase in Acute Respiratory Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tenecteplase in Acute Respiratory Failure report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tenecteplase in Acute Respiratory Failure Drug Details: Tenecteplase (Metalyse, Tnkase)...